Xiao-Jing Wang
Title | Affiliate |
---|
Institution | University of Colorado Denver - Anschutz Medical Campus |
---|
Department | SOM-Pathology |
---|
|
|
|
Research SB1DE024659 (YOUNG, CHRISTIAN)Sep 21, 2023 - Aug 31, 2025 NIH IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients Role: Co-Principal Investigator |
| IK6BX006039 (WANG, XIAO-JING)Apr 1, 2022 - Mar 31, 2027 NIH BLRD Research Career Scientist Award Application Role: Principal Investigator |
| P50CA261605 (JIMENO, ANTONIO)Sep 1, 2021 - Aug 31, 2026 NIH Colorado Head and Neck Cancer SPORE Role: Co-Principal Investigator |
| R44AR078669 (YOUNG, CHRISTIAN)Sep 24, 2020 - Aug 31, 2022 NIH Proprietary drug to treat radiodermatitis Role: Co-Principal Investigator |
| R01DE028420 (WANG, XIAO-JING)Jan 1, 2019 - Dec 31, 2024 NIH Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCC Role: Principal Investigator |
| R01DE027329 (WANG, JING HONG ;WANG, XIAO-JING)Aug 9, 2018 - Jul 31, 2023 NIH Elucidating Mechanism of Immune Evasion in Head and Neck Cancers Role: Principal Investigator |
| I01BX003232 (WANG, XIAO-JING)Oct 1, 2016 - Jun 30, 2026 NIH Mechanisms and Therapeutic Targets of SCC Metastasis Role: Principal Investigator |
| R44DE024659 (YOUNG, CHRISTIAN)Sep 15, 2014 - Aug 31, 2021 NIH Topical proprietary biologic to treat oral mucositis Role: Co-Principal Investigator |
| R43DE024659 (TURNER, BRIAN CURTIS)Sep 15, 2014 - Feb 28, 2017 NIH Smad7 use in oral mucositis treatment Role: Co-Principal Investigator |
| R44DE028718 (YOUNG, CHRISTIAN)Sep 1, 2014 - Aug 31, 2021 NIH Proprietary biologic treatment to heal skin wounds Role: Co-Principal Investigator |
| R41AR067106 (WANG, XIAO-JING)Sep 1, 2014 - Aug 31, 2016 NIH Testing Smad7-based biologics for treating chronic wounds Role: Principal Investigator |
| R01DE024371 (WANG, XIAO-JING)Aug 1, 2014 - Jul 31, 2019 NIH Identifying oral cancer stem cell properties affected by the microenvironment Role: Principal Investigator |
| T32CA174648 (KARAM, SANA)Apr 1, 2013 - Jun 30, 2024 NIH Training in Translational Research of Lung, Head and Neck Cancer Role: Principal Investigator |
| R01AR061792 (WANG, XIAO-JING)Jul 18, 2011 - Jun 30, 2017 NIH Effects of Altering TGF Beta Signaling on Wound Healing Role: Principal Investigator |
| RC1DE020649 (WANG, XIAO-JING)Sep 17, 2009 - Aug 31, 2011 NIH Identification of normal and cancer stem cells and their niche in oral mucosa Role: Principal Investigator |
| R01GM070966 (WANG, XIAO-JING)Apr 1, 2004 - Mar 31, 2009 NIH Effects of altering TGF beta signaling on wound healing Role: Principal Investigator |
| R01DE015953 (WANG, XIAO-JING)Mar 1, 2004 - Jan 31, 2016 NIH Role of TGFbeta signaling in HNSCC progression Role: Principal Investigator |
| R01CA087849 (WANG, XIAO-JING)Jul 1, 2000 - Jul 31, 2013 NIH Role of Smads in the epidermis and skin carcinogenesis Role: Principal Investigator |
| R01CA079998 (WANG, XIAO-JING)Jan 1, 1999 - Apr 30, 2011 NIH Role of TGF beta Signaling in skin carcinogenesis Role: Principal Investigator |
| R41ES007597 (WANG, XIAO-JING)Sep 30, 1995 - Sep 29, 1996 NIH CARCINOGENICITY ASSAY USING TRANSGENIC KERATINOCYTES Role: Principal Investigator |
Bibliographic
-
Malkoski SP, Haeger SM, Cleaver TG, Rodriguez KJ, Li H, Lu SL, Feser WJ, Bar?n AE, Merrick D, Lighthall JG, Ijichi H, Franklin W, Wang XJ. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. Clin Cancer Res. 2012 Apr 15; 18(8):2173-83. PMID: 22399565.
-
Malkoski SP, Wang XJ. Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer. FEBS Lett. 2012 Jul 04; 586(14):1984-92. PMID: 22321641.
-
Han G, Li F, Singh TP, Wolf P, Wang XJ. The pro-inflammatory role of TGF?1: a paradox? Int J Biol Sci. 2012; 8(2):228-35. PMID: 22253566.
-
Han G, Wang XJ. Roles of TGF? signaling Smads in squamous cell carcinoma. Cell Biosci. 2011 Dec 28; 1:41. PMID: 22204491.
-
Minor J, Wang X, Zhang F, Song J, Jimeno A, Wang XJ, Lu X, Gross N, Kulesz-Martin M, Wang D, Lu SL. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol. 2012 Jan; 48(1):73-8. PMID: 22133638.
-
Han G, Li F, Ten Dijke P, Wang XJ. Temporal smad7 transgene induction in mouse epidermis accelerates skin wound healing. Am J Pathol. 2011 Oct; 179(4):1768-79. PMID: 21944279.
-
Deng Y, Deng H, Liu J, Han G, Malkoski S, Liu B, Zhao R, Wang XJ, Zhang Q. Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer. Mol Carcinog. 2012 Jun; 51(6):500-7. PMID: 21681822.
-
Deng Y, Liu J, Han G, Lu SL, Wang SY, Malkoski S, Tan AC, Deng C, Wang XJ, Zhang Q. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene. 2010 Dec 16; 29(50):6603-8. PMID: 20818429.
-
Malkoski SP, Cleaver TG, Lu SL, Lighthall JG, Wang XJ. Keratin promoter based gene manipulation in the murine conducting airway. Int J Biol Sci. 2010 Jan 20; 6(1):68-79. PMID: 20140084.
-
Han G, Williams CA, Salter K, Garl PJ, Li AG, Wang XJ. A role for TGFbeta signaling in the pathogenesis of psoriasis. J Invest Dermatol. 2010 Feb; 130(2):371-7. PMID: 19710682.
-
Hoot KE, Lighthall J, Han G, Lu SL, Li A, Ju W, Kulesz-Martin M, Bottinger E, Wang XJ. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest. 2008 Aug; 118(8):2722-32. PMID: 18618014.
-
Owens P, Bazzi H, Engelking E, Han G, Christiano AM, Wang XJ. Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity. Dev Biol. 2008 Oct 01; 322(1):156-66. PMID: 18692037.
-
Han G, Li AG, Liang YY, Owens P, He W, Lu S, Yoshimatsu Y, Wang D, Ten Dijke P, Lin X, Wang XJ. Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev Cell. 2006 Sep; 11(3):301-12. PMID: 16950122.
-
Lu SL, Herrington H, Reh D, Weber S, Bornstein S, Wang D, Li AG, Tang CF, Siddiqui Y, Nord J, Andersen P, Corless CL, Wang XJ. Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev. 2006 May 15; 20(10):1331-42. PMID: 16702406.
-
Han G, Lu SL, Li AG, He W, Corless CL, Kulesz-Martin M, Wang XJ. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest. 2005 Jul; 115(7):1714-23. PMID: 15937546.
-
Li AG, Wang D, Feng XH, Wang XJ. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J. 2004 Apr 21; 23(8):1770-81. PMID: 15057277.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2004 | 1 | 2005 | 1 | 2006 | 2 | 2008 | 2 | 2009 | 1 | 2010 | 2 | 2011 | 4 | 2012 | 3 |
To return to the timeline, click here.
|
Wang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|